Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis
about
Immunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implicationsActivation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascadePleural mesothelial cells in pleural and lung diseasesVasculogenic mimicry and tumor angiogenesis.c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell linesIn vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors.Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis.HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.Eph receptors and ephrins as targets for cancer therapy.Delineating chromosomal breakpoints in radiation-induced papillary thyroid cancerEphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or LeukemiaExpression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.EphA2 as a promoter of melanoma tumorigenicityEffects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models.Receptor tyrosine kinases and their activation in melanoma.Eph-dependent cell-cell adhesion and segregation in development and cancer.The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications.EphA3 biology and cancer.Requirement for focal adhesion kinase in tumor cell adhesion.Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.Expression of NM23 in human melanoma progression and metastasis.The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization.EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase.Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.recessive spotting: a linked locus that interacts with W/Kit but is not allelic.High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia.An ephrin mimetic peptide that selectively targets the EphA2 receptor.Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions.Overexpression of the EphA2 tyrosine kinase in prostate cancer.
P2860
Q24798111-8936F657-1285-4E96-9A38-F3270FD09F48Q28210840-CEFA9FA3-38D3-4FCE-8A29-7B4519FC0905Q28396403-8C644764-47E0-4F5B-897C-0E4DD48E4637Q30498765-3B1D5A7A-838C-4E6F-99E5-7BAC9F6FBE74Q33565577-2610C53F-738C-4FA4-B1F9-BF5DD36A397BQ34030193-1FBD1080-2993-45E1-BD53-7F9B8388FFC4Q34872708-5B06163B-C0E1-414C-A1E8-498765813E7AQ34981712-9C7BA388-2ECA-492C-A923-1E7C816F991DQ35370195-2509590C-20A8-4C48-AB1F-65A30A8268F0Q35549967-248A83E3-6CA0-4BD7-BBAD-544FF9536063Q35666005-4FF60C4F-1631-45B7-8243-C8FD893B7AA8Q36295017-C2C82A63-D2C4-431A-AF29-26CF3CF485D5Q36379022-C1848466-1484-49AF-8140-3EB671A6D35DQ36936023-EF17E4EC-57E4-448D-A36C-D5FB107C8E13Q37615286-8AD1AA92-6A80-4802-BF60-D01FC23C8D21Q37625705-49A63E8E-548A-417B-91DD-54188C60AC5FQ37841746-25F89FBA-AD57-485F-84F2-36563FA64C6DQ37971902-18C07483-C8A9-42F5-A4CF-83D388F76FA4Q38058513-3FFB294D-0364-4716-A4C7-C5A89C25D312Q38267753-30C701E1-B9D8-459F-8DC4-88F7704683AEQ38317565-64BA9A7E-335F-4D36-8123-30D7399104D9Q38809327-0DE8D64C-8A45-4C26-AD2A-865BBA3680D1Q39051391-21214F83-1AD8-48E3-A612-16EBEE7F072CQ39996458-86A0C38C-7CBA-49FC-92A9-E7F64DC6409FQ40236645-0FC745BD-1F75-45F6-8657-71277D375572Q40392006-A2ACA427-5360-4380-9D7B-31FD269B7AF5Q40423673-86D1C914-089C-4BDF-BB39-4DA699BBD68EQ41025697-7F70AECD-352E-400A-8653-62E43A409BA3Q42071638-550D6C0D-3E75-418F-910E-3B6BD0051842Q44156005-2E6DCDC2-5D49-4923-A5F5-802CDA6F2FDFQ47404143-0903CFCD-8058-4BA5-A475-0CCBC1A43EADQ53417449-6288DC98-C138-4410-9FDF-3E40CA5B0AE9
P2860
Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Abnormal protein tyrosine kina ...... oma progression and metastasis
@ast
Abnormal protein tyrosine kina ...... oma progression and metastasis
@en
Abnormal protein tyrosine kina ...... oma progression and metastasis
@nl
type
label
Abnormal protein tyrosine kina ...... oma progression and metastasis
@ast
Abnormal protein tyrosine kina ...... oma progression and metastasis
@en
Abnormal protein tyrosine kina ...... oma progression and metastasis
@nl
prefLabel
Abnormal protein tyrosine kina ...... oma progression and metastasis
@ast
Abnormal protein tyrosine kina ...... oma progression and metastasis
@en
Abnormal protein tyrosine kina ...... oma progression and metastasis
@nl
P2093
P2860
P356
P1476
Abnormal protein tyrosine kina ...... oma progression and metastasis
@en
P2093
P2860
P304
P356
10.1002/IJC.2910600119
P407
P577
1995-01-03T00:00:00Z